A rare hybrid. A change agent. A trusted partner.
NGOtiate is a Danish consultency house with a global commitment, scope and client base.
We specialize in enabling patient alliances and health care companies (biotech, pharma and Med/AITech) to deliver a bigger impact for patients through strategic partnerships. We design related alliance strategies, plans and initiatives, and we support their implementation from A-Z.
We think and act beyond unmet medical needs to help resolve unmet patient needs.
We pay it forward. We offer reduced fee-for-service rates to all non-profit organizations and alliances and zero-fee advice to individuals seeking to establish a patient organization or alliance.
We enable organizations to lead the change they envisage. And patients need.
Since 2010, we have been operating at the intersection of non-profit patient alliances and commercial life sciences companies sparking first-in-class and best-in-class partnerships leading to life-changing outcomes for patients.
We help leaderships of patient alliances and companies by developing related strategies and tactics, and by connecting the right organizations at the right time. The related mission may be to pave the way for a first-ever or best-ever treatment. It may also be: To establish the data foundation and evidence for the implied needs and benefits for patients and society at large. Or it may be very fundamental: To help organizations at both sides build the internal capabilities, knowledge and readiness needed in the first place, to pursue the change they envisage and patients need.
When supporting ambitions to bring first-in-class and best-in-class disease initiatives and interventions into reality, we work as a strategic and operational partner and catalyst across the intervention ideation, research, development, approval and launch phases. When the intervention is a pharmaceutical product, this role implies ensuring that patient engagement is not symbolic, but indeed scientifically sound, regulatorily credible and outcome-centric. To that end, we apply and are led by data, evidence-based methodologies and regulatory guidance (EMA/FDA).
We are visionary doers and second-to-none partners.
Driving change through enactment – we help organizations leading change via becoming it.
Enabling patient organizations and alliances
We help patient organizations and alliances create and operationalize strategies that enable and position them as indispensable partners to life sciences companies committed to developing and delivering first-in-class or best-in-class solutions to patients.
Strategic patient engagement for life sciences
We help pharma, biotech, and medtech companies design and apply strategic patient engagement that informs new product planning, de-risks R&D, supports regulatory readiness, and strengthens market access strategies — in alignment with FDA and EMA expectations.
Partnership and alliance design
We design governance models, collaboration frameworks, and alliance strategies that allow patient-derived RWE, scientific rigor, and regulatory guardrails to coexist and reinforce one another across the full value chain.
First-in-class initiatives
We invent and deliver pioneering initiatives that generate novel data, insights, and evidence to support first-in-class and best-in-class solutions — beyond the molecule and beyond conventional engagement models.
Our services for patient organizations and alliances
Strategy, positioning, and capability building
We help patient organizations and alliances define purpose, strategic positioning, and operational readiness so they can engage with life sciences companies as credible and compliant partners.
Community building, campaigns, and activation
We design and deliver tailored programs that support awareness, education, advocacy, and community activation — always grounded in unmet patient needs and lived experience.
Partnering in innovation and R&D
We enable patient organizations to participate meaningfully in innovation, research, and development by identifying the right partners and building compliant engagement frameworks that drive measurable outcomes.
Nothing for Patients Without Patients is not a slogan — it is a structured, operational principle.
Our services for life sciences companies
Strategic patient engagement across the value chain
We design and apply strategic patient engagement that informs new product planning, de-risks R&D, supports regulatory readiness, and strengthens market access strategies — aligned with FDA and EMA expectations.
Flagship programs and differentiated value propositions
We design second-to-none initiatives that demonstrate differentiated value to the “5 Ps”: patients, physicians, payers, policy-makers, and the public — measurable, compliant, and strategically aligned.
Partnering in innovation
We connect companies with the right patient organizations and individuals and build win-win engagement platforms — from governance to execution — to drive outcomes.
Ongoing expert support
We provide continuous, hands-on advisory support to help organizations apply patient engagement as a driver of innovation, R&D excellence, regulatory robustness, and commercial leadership.
How we are different
The partnering paradigm. Our laser focus is on the white space where unmet patient needs intersect with the scientific, regulatory, and operational requirements of developing approvable healthcare solutions.
Key examples on how and where our services are applied in the pharmaceutical R&D process:
We operate across the full solution lifecycle — from ideation through research, development, and approval — enabling the structured flow from lived patient experience to real-world evidence (RWE), and onward into strategies and operations across new product planning, R&D, regulatory strategy and submission readiness, market access, and market leadership.
Central to this model is the role of patient organizations and alliances as partners that are enabled and positioned to become structurally embedded across ideation, research, development, and approval — consistent with the principle of Nothing for Patients Without Patients.
NGOtiate does not replace sponsors, developers, or regulators. We facilitate alignment, translation, and de-risking, ensuring that patient-derived insights, data and RWE can be credibly optained and applied within the relevant frameworks and decision-making environments.
Leadership
Contact
Let’s talk. We’re here to help.
contact@ngotiate.com
+45 911 911 00
NGOtiate – Ny Carlsberg Vej 23 – DK 1760 – Copenhagen V – Denmark – CVR 25316045